Results 241 to 250 of about 207,668 (337)

Constitutional symptoms and response to Penicillin G in erysipelas and cellulitis – a monocentric, retrospective, explorative study

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background: Erysipelas, caused by streptococci, should be treated with penicillin, while uncomplicated cellulitis (phlegmon), often caused by Staphylococcus aureus, requires penicillinase‐resistant beta‐lactam antibiotics, which have a higher risk of adverse effects. Distinguishing between these infections is important.
Helena Schieffers, Cord Sunderkötter
wiley   +1 more source

Higher risk behaviours and STD rates in Tanzania compared to Uganda - contribution to different outcomes of STD treatment trials? [abstract] [PDF]

open access: yes, 2001
Grosskurth, H   +9 more
core  

Outdoor work as risk factor for facial melanoma: UV exposure, risk awareness, and occupational relevance

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background This study explored UV exposure and prevention behaviors among melanoma patients, focusing on occupational UV exposure, melanoma characteristics, risk awareness, and protective behaviors. Patients and Methods This cross‐sectional study analyzed demographics, melanoma characteristics, UV exposure, awareness, and preventive measures ...
Susanne Dugas‐Breit   +3 more
wiley   +1 more source

Mpox, HIV Infection, and Genital Skin Disease: Triple Burden, Threats and Challenges from an Epidemiological Perspective

open access: hybrid
I Made Dwi Mertha Adnyana   +6 more
openalex   +2 more sources

Efficacy and safety of combining empagliflozin in people with type 2 diabetes mellitus uncontrolled with metformin and sitagliptin: A randomised, double‐blind, multicentre, therapeutic confirmatory phase 3 clinical trial

open access: yesDiabetes, Obesity and Metabolism, EarlyView.
Abstract Aim This study evaluated the efficacy and safety of empagliflozin 10 and 25 mg compared to placebo as add‐on treatment for people with type 2 diabetes mellitus (T2DM) uncontrolled after ≥8 weeks of treatment with metformin and sitagliptin. Materials and Methods A randomised, double‐blind, multicentre, therapeutic confirmatory, phase 3 clinical
Seung‐Hwan Lee   +15 more
wiley   +1 more source

Home - About - Disclaimer - Privacy